Compare · IRMD vs MDLN
IRMD vs MDLN
Side-by-side comparison of iRadimed Corporation (IRMD) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both IRMD and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $47.24B, about 41.1x IRMD ($1.15B).
- Over the past year, IRMD is up 18.0% and MDLN is down 10.2% - IRMD leads by 28.2 points.
- MDLN has been more active in the news (7 items in the past 4 weeks vs 3 for IRMD).
- MDLN has more recent analyst coverage (25 ratings vs 2 for IRMD).
- Company
- iRadimed Corporation
- Medline Inc.
- Price
- $89.51-0.37%
- $36.59+1.85%
- Market cap
- $1.15B
- $47.24B
- 1M return
- +8.44%
- +10.90%
- 1Y return
- +17.96%
- -10.21%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2014
- 2025
- News (4w)
- 3
- 7
- Recent ratings
- 2
- 25
iRadimed Corporation
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
Latest IRMD
- Director Kiani Joe E converted options into 698 shares (SEC Form 4)
- IRADIMED CORPORATION To Participate in the 5th Annual ROTH Healthcare Opportunities Conference
- Needham initiated coverage on iRadimed
- Director Allen Monty K sold $122,622 worth of shares (1,419 units at $86.41), decreasing direct ownership by 7% to 19,581 units (SEC Form 4)
- SEC Form 144 filed by iRadimed Corporation
- Amendment: iRadimed Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits, Other Events
- SEC Form 10-Q filed by iRadimed Corporation
- iRadimed Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results
- IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026
Latest MDLN
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- SEC Form 4 filed by Medline Inc.
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- SEC Form 4 filed by Medline Inc.
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M